{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:40:53Z","timestamp":1792024853127,"version":"4.4.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014035","name":"Armed Forces Health Surveillance Branch","doi-asserted-by":"publisher","award":["ID P001_20_WR"],"award-info":[{"award-number":["ID P001_20_WR"]}],"id":[{"id":"10.13039\/100014035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Extra-intestinal pathogenic<jats:italic>Escherichia coli<\/jats:italic>(ExPEC) are a leading cause of bloodstream and urinary tract infections worldwide. Over the last two decades, increased rates of antibiotic resistance in<jats:italic>E. coli<\/jats:italic>have been reported, further complicating treatment. Worryingly, specific lineages expressing extended-spectrum<jats:italic>\u03b2<\/jats:italic>-lactamases (ESBLs) and fluoroquinolone resistance have proliferated and are now considered a serious threat. Obtaining contemporary information on the epidemiology and prevalence of these circulating lineages is critical for containing their spread globally and within the clinic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Whole-genome sequencing (WGS), phylogenetic analysis, and antibiotic susceptibility testing were performed for a complete set of 2075<jats:italic>E. coli<\/jats:italic>clinical isolates collected from 1776 patients at a large tertiary healthcare network in the USA between October 2019 and September 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The isolates represented two main phylogenetic groups, B2 and D, with six lineages accounting for 53% of strains: ST-69, ST-73, ST-95, ST-131, ST-127, and ST-1193. Twenty-seven percent of the primary isolates were multidrug resistant (MDR) and 5% carried an ESBL gene. Importantly, 74% of the ESBL<jats:italic>-E.coli<\/jats:italic>were co-resistant to fluoroquinolones and mostly belonged to pandemic ST-131 and emerging ST-1193. SNP-based detection of possible outbreaks identified 95 potential transmission clusters totaling 258 isolates (12% of the whole population) from \u2265 2 patients. While the proportion of MDR isolates was enriched in the set of putative transmission isolates compared to sporadic infections (35 vs 27%,<jats:italic>p<\/jats:italic>= 0.007), a large fraction (61%) of the predicted outbreaks (including the largest cluster grouping isolates from 12 patients) were caused by the transmission of non-MDR clones.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By coupling in-depth genomic characterization with a complete sampling of clinical isolates for a full year, this study provides a rare and contemporary survey on the epidemiology and spread of<jats:italic>E. coli<\/jats:italic>in a large US healthcare network. While surveillance and infection control efforts often focus on ESBL and MDR lineages, our findings reveal that non-MDR isolates represent a large burden of infections, including those of predicted nosocomial origins. This increased awareness is key for implementing effective WGS-based surveillance as a routine technology for infection control.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13073-022-01150-7","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T10:12:21Z","timestamp":1672395141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A one-year genomic investigation of Escherichia coli epidemiology and nosocomial spread at a large US healthcare network"],"prefix":"10.1186","volume":"14","author":[{"given":"Emma G.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting L.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosslyn","family":"Maybank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan W.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Harless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan N.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Rosado-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon I.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Backlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Mc Gann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-5026","authenticated-orcid":false,"given":"Francois","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"10","key":"1150_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S1473-3099(18)30353-0","volume":"18","author":"KD Vihta","year":"2018","unstructured":"Vihta KD, Stoesser N, Llewelyn MJ, Quan TP, Davies T, Fawcett NJ, et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998\u20132016: a study of electronic health records. Lancet Infect Dis. 2018;18(10):1138\u201349.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"1150_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384.","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"1150_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220265","volume":"14","author":"IA Critchley","year":"2019","unstructured":"Critchley IA, Cotroneo N, Pucci MJ, Mendes R. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS One. 2019;14(12):e0220265.","journal-title":"PLoS One"},{"key":"1150_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13756-019-0590-7","volume":"8","author":"X Zhen","year":"2019","unstructured":"Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8:137.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"1150_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221944","volume":"14","author":"NR Naylor","year":"2019","unstructured":"Naylor NR, Pouwels KB, Hope R, Green N, Henderson KL, Knight GM, et al. The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: a national retrospective cohort study. PLoS One. 2019;14(9):e0221944.","journal-title":"PLoS One"},{"issue":"7","key":"1150_CR6","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1128\/AAC.00405-16","volume":"60","author":"HS Sader","year":"2016","unstructured":"Sader HS, Castanheira M, Flamm RK, Jones RN. Antimicrobial activities of ceftazidime-avibactam and comparator agents against Gram-negative organisms isolated from patients with urinary tract infections in U.S. medical centers, 2012 to 2014. Antimicrob Agents Chemother. 2016;60(7):4355\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"1150_CR7","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1128\/AAC.46.8.2540-2545.2002","volume":"46","author":"JA Karlowsky","year":"2002","unstructured":"Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002;46(8):2540\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1150_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4269\/ajtmh.18-0394","volume":"100","author":"P Sawatwong","year":"2019","unstructured":"Sawatwong P, Sapchookul P, Whistler T, Gregory CJ, Sangwichian O, Makprasert S, et al. High burden of extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae bacteremia in older adults: a seven-year study in two rural Thai provinces. Am J Trop Med Hyg. 2019;100(4):943\u201351.","journal-title":"Am J Trop Med Hyg"},{"key":"1150_CR9","doi-asserted-by":"crossref","unstructured":"Ludden C, Coll F, Gouliouris T, Restif O, Blane B, Blackwell GA, et al. Defining nosocomial transmission of Escherichia coli and antimicrobial resistance genes: a genomic surveillance study. Lancet. Microbe. 2021;0(0). 2021;2(9):e472-80.","DOI":"10.1016\/S2666-5247(21)00117-8"},{"key":"1150_CR10","doi-asserted-by":"crossref","unstructured":"Raphael E, Glymour MM, Chambers HF. Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system. Antimicrob Resist Infect Control. 2021;10(1):118.","DOI":"10.1186\/s13756-021-00983-y"},{"key":"1150_CR11","unstructured":"Centers for Disease Control and Prevention (U.S.). Antibiotic resistance threats in the United States, 2019 [Internet]. Centers for Disease Control and Prevention (U.S.); 2019. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/82532. [Cited 2021 May 24]."},{"key":"1150_CR12","doi-asserted-by":"crossref","unstructured":"Denamur E, Clermont O, Bonacorsi S, Gordon D. The population genetics of pathogenic Escherichia coli. Nat Rev Microbiol. 2021;19(1):37-45.","DOI":"10.1038\/s41579-020-0416-x"},{"issue":"1","key":"1150_CR13","doi-asserted-by":"publisher","first-page":"5968","DOI":"10.1038\/s41467-020-19714-9","volume":"11","author":"M Biggel","year":"2020","unstructured":"Biggel M, Xavier BB, Johnson JR, Nielsen KL, Frimodt-M\u00f8ller N, Matheeussen V, et al. Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages. Nat Commun. 2020;11(1):5968.","journal-title":"Nat Commun"},{"issue":"2","key":"1150_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"1150_CR15","doi-asserted-by":"publisher","first-page":"F1000 Faculty R","DOI":"10.12688\/f1000research.10609.1","volume":"6","author":"JDD Pitout","year":"2017","unstructured":"Pitout JDD, DeVinney R. Escherichia coli ST131: a multidrug-resistant clone primed for global domination. F1000Research. 2017;6:F1000 Faculty Rev-195.","journal-title":"F1000Research"},{"key":"1150_CR16","doi-asserted-by":"crossref","unstructured":"Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, et al. The epidemic of extended-spectrum-\u03b2-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio. 2013;4(6): e00377-13.","DOI":"10.1128\/mBio.00377-13"},{"issue":"6","key":"1150_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/infdis\/jis933","volume":"207","author":"JR Johnson","year":"2013","unstructured":"Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis. 2013;207(6):919\u201328.","journal-title":"J Infect Dis"},{"issue":"11","key":"1150_CR18","first-page":"ofz431","volume":"6","author":"CD Fibke","year":"2019","unstructured":"Fibke CD, Croxen MA, Geum HM, Glass M, Wong E, Avery BP, et al. Genomic epidemiology of major extraintestinal pathogenic Escherichia coli lineages causing urinary tract infections in young women across Canada. Open Forum. Infect Dis Ther. 2019;6(11):ofz431.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"1150_CR19","doi-asserted-by":"publisher","first-page":"e01834","DOI":"10.1128\/JCM.01834-17","volume":"56","author":"R Yamaji","year":"2018","unstructured":"Yamaji R, Rubin J, Thys E, Friedman CR, Riley LW. Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017. Diekema DJ, editor. J Clin Microbiol. 2018;56(4):e01834\u201317.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1150_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1101\/gr.216606.116","volume":"27","author":"T Kallonen","year":"2017","unstructured":"Kallonen T, Brodrick HJ, Harris SR, Corander J, Brown NM, Martin V, et al. Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res. 2017;27(8):1437\u201349.","journal-title":"Genome Res"},{"issue":"5","key":"1150_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006496","volume":"15","author":"A Duval","year":"2019","unstructured":"Duval A, Obadia T, Bo\u00eblle PY, Fleury E, Herrmann JL, Guillemot D, et al. Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings. PLoS Comput Biol. 2019;15(5):e1006496.","journal-title":"PLoS Comput Biol"},{"key":"1150_CR22","unstructured":"CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. CLSI standard M07. Wayne, PA: Clinical and Laboratory Standards Institute; 2018."},{"issue":"10","key":"1150_CR23","doi-asserted-by":"publisher","first-page":"e00840","DOI":"10.1128\/AAC.00840-20","volume":"64","author":"MR Galac","year":"2020","unstructured":"Galac MR, Snesrud E, Lebreton F, Stam J, Julius M, Ong AC, et al. A diverse panel of clinical Acinetobacter baumannii for research and development. Antimicrob Agents Chemother. 2020;64(10):e00840\u201320 \/aac\/64\/10\/AAC.00840-20.atom.","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"1150_CR24","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068\u20139.","journal-title":"Bioinformatics."},{"issue":"1","key":"1150_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257.","journal-title":"Genome Biol"},{"key":"1150_CR26","doi-asserted-by":"crossref","unstructured":"Waters NR, Abram F, Brennan F, Holmes A, Pritchard L. Easy phylotyping of Escherichia coli via the EzClermont web app and command-line tool. Access Microbiol. 2020;2(9):acmi000143.","DOI":"10.1099\/acmi.0.000143"},{"issue":"1","key":"1150_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/1758-2229.12019","volume":"5","author":"O Clermont","year":"2013","unstructured":"Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5(1):58\u201365.","journal-title":"Environ Microbiol Rep"},{"key":"1150_CR28","unstructured":"Seeman T. mlst - scan contig files against traditional PubMLST typing schemes. Available from: https:\/\/github.com\/tseemann\/mlst. [Accessed 2020 Jan 4]."},{"key":"1150_CR29","doi-asserted-by":"crossref","unstructured":"Jolley KA, Bray J, Maiden MC. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;(3):124 https:\/\/pubmlst.org\/. Accessed 4 January 2020.","DOI":"10.12688\/wellcomeopenres.14826.1"},{"issue":"1","key":"1150_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1101\/gr.251678.119","volume":"30","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Alikhan NF, Mohamed K, Fan Y, the Agama Study Group, Achtman M. The EnteroBase user\u2019s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020;30(1):138\u201352.","journal-title":"Genome Res"},{"issue":"21","key":"1150_CR31","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1093\/bioinformatics\/btz220","volume":"35","author":"NM Quijada","year":"2019","unstructured":"Quijada NM, Rodr\u00edguez-L\u00e1zaro D, Eiros JM, Hern\u00e1ndez M. TORMES: an automated pipeline for whole bacterial genome analysis. Bioinformatics. 2019;35(21):4207\u201312.","journal-title":"Bioinformatics."},{"issue":"8","key":"1150_CR32","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/JCM.00008-15","volume":"53","author":"KG Joensen","year":"2015","unstructured":"Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol. 2015;53(8):2410\u201326.","journal-title":"J Clin Microbiol"},{"key":"1150_CR33","doi-asserted-by":"crossref","unstructured":"Roer L, Tchesnokova V, Alles\u00f8e R, Muradova M, Chattopadhyay S, Ahrenfeldt J, et al. Development of a web tool for Escherichia coli subtyping based on fimH alleles. J Clin Microbiol. 2017;55(8):2538\u201343.","DOI":"10.1128\/JCM.00737-17"},{"issue":"11","key":"1150_CR34","doi-asserted-by":"publisher","first-page":"e00483","DOI":"10.1128\/AAC.00483-19","volume":"63","author":"M Feldgarden","year":"2019","unstructured":"Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ, Tolstoy I, et al. Validating the AMRFinder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates. Antimicrob Agents Chemother. 2019;63(11):e00483\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"1150_CR35","doi-asserted-by":"crossref","unstructured":"Hunt M, Mather AE, S\u00e1nchez-Bus\u00f3 L, Page AJ, Parkhill J, Keane JA, et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb. Genomics. 2017;3(10):e000131.","DOI":"10.1099\/mgen.0.000131"},{"issue":"7","key":"1150_CR36","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1128\/AAC.02412-14","volume":"58","author":"A Carattoli","year":"2014","unstructured":"Carattoli A, Zankari E, Garc\u00eda-Fern\u00e1ndez A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895\u2013903.","journal-title":"Antimicrob Agents Chemother"},{"issue":"D1","key":"1150_CR37","doi-asserted-by":"publisher","first-page":"D694","DOI":"10.1093\/nar\/gkv1239","volume":"44","author":"L Chen","year":"2016","unstructured":"Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: hierarchical and refined dataset for big data analysis\u201410 years on. Nucleic Acids Res. 2016;44(D1):D694\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1150_CR38","doi-asserted-by":"publisher","unstructured":"Biggel, M. EcVGDB. Zenodo [Internet]. 2020; Available from: https:\/\/doi.org\/10.5281\/zenodo.4079473.","DOI":"10.5281\/zenodo.4079473"},{"key":"1150_CR39","unstructured":"Seemann T. ABRicate - mass screening of contigs for antimicrobial resistance or virulence genes. Available from: https:\/\/github.com\/tseemann\/abricate. [Accessed 2022 Feb 23]."},{"issue":"22","key":"1150_CR40","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/bioinformatics\/btv421","volume":"31","author":"AJ Page","year":"2015","unstructured":"Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691\u20133.","journal-title":"Bioinformatics."},{"key":"1150_CR41","unstructured":"Seeman T. snippy - rapid haploid variant calling and core genome alignment. Available from: https:\/\/github.com\/tseemann\/abricate. [Accessed 2019 Sep 25]."},{"issue":"11","key":"1150_CR42","doi-asserted-by":"publisher","first-page":"e112963","DOI":"10.1371\/journal.pone.0112963","volume":"9","author":"BJ Walker","year":"2014","unstructured":"Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One. 2014;9(11):e112963.","journal-title":"PLoS One"},{"issue":"3","key":"1150_CR43","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/nar\/gku1196","volume":"43","author":"NJ Croucher","year":"2015","unstructured":"Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43(3):e15.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1150_CR44","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","volume":"30","author":"A Stamatakis","year":"2014","unstructured":"Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30(9):1312\u20133.","journal-title":"Bioinformatics."},{"issue":"W1","key":"1150_CR45","doi-asserted-by":"publisher","first-page":"W256","DOI":"10.1093\/nar\/gkz239","volume":"47","author":"I Letunic","year":"2019","unstructured":"Letunic I, Bork P. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res. 2019;47(W1):W256\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1150_CR46","doi-asserted-by":"crossref","unstructured":"Stoesser N, Sheppard AE, Pankhurst L, De Maio N, Moore CE, Sebra R, et al. Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. mBio. 2016;7(2):e02162.","DOI":"10.1128\/mBio.02162-15"},{"issue":"4","key":"1150_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nbt.2522","volume":"31","author":"S J\u00fcnemann","year":"2013","unstructured":"J\u00fcnemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, et al. Updating benchtop sequencing performance comparison. Nat Biotechnol. 2013;31(4):294\u20136.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1150_CR48","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41564-022-01079-y","volume":"7","author":"DM Muloi","year":"2022","unstructured":"Muloi DM, Wee BA, McClean DMH, Ward MJ, Pankhurst L, Phan H, et al. Population genomics of Escherichia coli in livestock-keeping households across a rapidly developing urban landscape. Nat Microbiol. 2022;7(4):581\u20139.","journal-title":"Nat Microbiol"},{"issue":"5","key":"1150_CR49","doi-asserted-by":"publisher","first-page":"e01664","DOI":"10.1128\/JCM.01664-18","volume":"57","author":"JR Johnson","year":"2019","unstructured":"Johnson JR, Johnston BD, Porter SB, Clabots C, Bender TL, Thuras P, et al. Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64, a new disseminated multidrug-resistant commensal and extraintestinal pathogen. J Clin Microbiol. 2019;57(5):e01664\u201318.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1150_CR50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1150_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12879-016-1527-x","volume":"16","author":"SE Mshana","year":"2016","unstructured":"Mshana SE, Falgenhauer L, Mirambo MM, Mushi MF, Moremi N, Julius R, et al. Predictors of blaCTX-M-15 in varieties of Escherichia coli genotypes from humans in community settings in Mwanza, Tanzania. BMC Infect Dis. 2016;16(1):187.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"1150_CR52","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S1473-3099(19)30273-7","volume":"19","author":"MJ Day","year":"2019","unstructured":"Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N, Randall L, et al. Extended-spectrum \u03b2-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. Lancet Infect Dis. 2019;19(12):1325\u201335.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"1150_CR53","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jac\/dkx006","volume":"72","author":"S Guenther","year":"2017","unstructured":"Guenther S, Semmler T, Stubbe A, Stubbe M, Wieler LH, Schaufler K. Chromosomally encoded ESBL genes in Escherichia coli of ST38 from Mongolian wild birds. J Antimicrob Chemother. 2017;72(5):1310\u20133.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1150_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41598-019-56763-7","volume":"10","author":"K Kondratyeva","year":"2020","unstructured":"Kondratyeva K, Salmon-Divon M, Navon-Venezia S. Meta-analysis of pandemic Escherichia coli ST131 plasmidome proves restricted plasmid-clade associations. Sci Rep. 2020;10(1):36.","journal-title":"Sci Rep"},{"issue":"1","key":"1150_CR55","doi-asserted-by":"publisher","first-page":"44866","DOI":"10.1038\/srep44866","volume":"7","author":"L Xia","year":"2017","unstructured":"Xia L, Liu Y, Xia S, Kudinha T, Xiao SN, Zhong NS, et al. Prevalence of ST1193 clone and IncI1\/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China. Sci Rep. 2017;7(1):44866.","journal-title":"Sci Rep"},{"issue":"5","key":"1150_CR56","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/jac\/dkg222","volume":"51","author":"J Ruiz","year":"2003","unstructured":"Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51(5):1109\u201317.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1150_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13099-019-0290-0","volume":"11","author":"J Sarowska","year":"2019","unstructured":"Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 2019;11(1):10.","journal-title":"Gut Pathog"},{"issue":"2","key":"1150_CR58","doi-asserted-by":"publisher","first-page":"e00347","DOI":"10.1128\/mBio.00347-16","volume":"7","author":"NL Ben Zakour","year":"2016","unstructured":"Ben Zakour NL, Alsheikh-Hussain AS, Ashcroft MM, Khanh Nhu NT, Roberts LW, Stanton-Cook M, et al. Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131. mBio. 2016;7(2):e00347\u201316.","journal-title":"mBio"},{"key":"1150_CR59","doi-asserted-by":"crossref","unstructured":"Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. Cent Eur. J Urol. 2015;68(4):452-458.","DOI":"10.5173\/ceju.2015.625"},{"issue":"1","key":"1150_CR60","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13073-017-0457-6","volume":"9","author":"HJ Brodrick","year":"2017","unstructured":"Brodrick HJ, Raven KE, Kallonen T, Jamrozy D, Blane B, Brown NM, et al. Longitudinal genomic surveillance of multidrug-resistant Escherichia coli carriage in a long-term care facility in the United Kingdom. Genome Med. 2017;9(1):70.","journal-title":"Genome Med"},{"issue":"12","key":"1150_CR61","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1093\/cid\/ciab006","volume":"73","author":"S Lipworth","year":"2021","unstructured":"Lipworth S, Vihta KD, Chau KK, Kavanagh J, Davies T, George S, et al. Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections. Clin Infect Dis. 2021;73(12):2276\u201382.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1150_CR62","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/S2666-5247(21)00031-8","volume":"2","author":"RA Gladstone","year":"2021","unstructured":"Gladstone RA, McNally A, P\u00f6ntinen AK, Tonkin-Hill G, Lees JA, Skyt\u00e9n K, et al. Emergence and dissemination of antimicrobial resistance in Escherichia coli causing bloodstream infections in Norway in 2002\u201317: a nationwide, longitudinal, microbial population genomic study. Lancet Microbe. 2021;2(7):e331\u201341.","journal-title":"Lancet Microbe"},{"issue":"1","key":"1150_CR63","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41598-022-05869-6","volume":"12","author":"S Mahazu","year":"2022","unstructured":"Mahazu S, Sato W, Ayibieke A, Prah I, Hayashi T, Suzuki T, et al. Insights and genetic features of extended-spectrum beta-lactamase producing Escherichia coli isolates from two hospitals in Ghana. Sci Rep. 2022;12(1):1843.","journal-title":"Sci Rep"},{"issue":"6","key":"1150_CR64","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archinte.166.6.635","volume":"166","author":"AJ Kallen","year":"2006","unstructured":"Kallen AJ, Welch HG, Sirovich BE. Current antibiotic therapy for isolated urinary tract infections in women. Arch Intern Med. 2006;166(6):635.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1150_CR65","doi-asserted-by":"publisher","first-page":"e01913","DOI":"10.1128\/AAC.01913-18","volume":"63","author":"TJ Johnson","year":"2019","unstructured":"Johnson TJ, Elnekave E, Miller EA, Munoz-Aguayo J, Flores Figueroa C, Johnston B, et al. Phylogenomic analysis of extraintestinal pathogenic Escherichia coli sequence type 1193, an emerging multidrug-resistant clonal group. Antimicrob Agents Chemother. 2019;63(1):e01913\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1150_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jgar.2019.01.014","volume":"17","author":"G Valenza","year":"2019","unstructured":"Valenza G, Werner M, Eisenberger D, Nickel S, Lehner-Reindl V, H\u00f6ller C, et al. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli from Germany. J Glob Antimicrob Resist. 2019;17:305\u20138.","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"1150_CR67","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cid\/ciy525","volume":"68","author":"VL Tchesnokova","year":"2019","unstructured":"Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, et al. Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193. Clin Infect Dis. 2019;68(2):334\u20137.","journal-title":"Clin Infect Dis"},{"key":"1150_CR68","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3389\/fmicb.2017.02294","volume":"8","author":"J Wu","year":"2017","unstructured":"Wu J, Lan F, Lu Y, He Q, Li B. Molecular characteristics of ST1193 clone among phylogenetic group B2 non-ST131 fluoroquinolone-resistant Escherichia coli. Front Microbiol. 2017;8:2294.","journal-title":"Front Microbiol"},{"key":"1150_CR69","doi-asserted-by":"crossref","unstructured":"Nguyen Q, Nguyen TTN, Pham P, Chau V, Nguyen LPH, Nguyen TD, et al. Genomic insights into the circulation of pandemic fluoroquinolone-resistant extra-intestinal pathogenic Escherichia coli ST1193 in Vietnam. Microb. Genomics. 2021;7(12):000733.","DOI":"10.1099\/mgen.0.000733"},{"issue":"29","key":"1150_CR70","doi-asserted-by":"publisher","first-page":"14740","DOI":"10.1073\/pnas.1903002116","volume":"116","author":"V Tchesnokova","year":"2019","unstructured":"Tchesnokova V, Radey M, Chattopadhyay S, Larson L, Weaver JL, Kisiela D, et al. Pandemic fluoroquinolone resistant Escherichia coli clone ST1193 emerged via simultaneous homologous recombinations in 11 gene loci. Proc Natl Acad Sci. 2019;116(29):14740\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"1150_CR71","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/cid\/ciab560","volume":"73","author":"KS Kaye","year":"2021","unstructured":"Kaye KS, Gupta V, Mulgirigama A, Joshi AV, Scangarella-Oman NE, Yu K, et al. Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rising ESBL strains and impact on patient management. Clin Infect Dis. 2021;73(11):1992\u20139.","journal-title":"Clin Infect Dis"},{"key":"1150_CR72","doi-asserted-by":"crossref","unstructured":"Kourtis AP, Sheriff EA, Weiner-Lastinger LM, Elmore K, Preston LE, Dudeck M, et al. Antibiotic multidrug resistance of Escherichia coli causing device- and procedure-related infections in the United States reported to the National Healthcare Safety Network, 2013\u20132017. Clin Infect Dis. 2021;73(11):e4552-59.","DOI":"10.1093\/cid\/ciaa1031"},{"issue":"10325","key":"1150_CR73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet."},{"key":"1150_CR74","doi-asserted-by":"crossref","unstructured":"Roberts LW, Hoi LT, Khokhar FA, Hoa NT, Giang TV, Bui C, et al. Genomic characterisation of multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: a prospective observational cohort study. Lancet Microbe. 2022;3(11):e857-e866.","DOI":"10.1016\/S2666-5247(22)00181-1"},{"issue":"8","key":"1150_CR75","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/jac\/dkx146","volume":"72","author":"ER Bevan","year":"2017","unstructured":"Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145\u201355.","journal-title":"J Antimicrob Chemother"},{"key":"1150_CR76","doi-asserted-by":"crossref","unstructured":"Birgy A, Bidet P, Levy C, Sobral E, Cohen R, Bonacorsi S. CTX-M-27-producing Escherichia coli of sequence type 131 and clade C1-M27, France. Emerg. Infect Dis. 2017; 23(5):885.","DOI":"10.3201\/eid2305.161865"},{"issue":"11","key":"1150_CR77","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3201\/eid2211.160519","volume":"22","author":"Y Matsumura","year":"2016","unstructured":"Matsumura Y, Pitout JDD, Gomi R, Matsuda T, Noguchi T, Yamamoto M, et al. Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene. Emerg Infect Dis. 2016;22(11):1900\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"1150_CR78","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3201\/eid2310.170938","volume":"23","author":"H Ghosh","year":"2017","unstructured":"Ghosh H, Doijad S, Falgenhauer L, Fritzenwanker M, Imirzalioglu C, Chakraborty T. blaCTX-M-27 \u2013encoding Escherichia coli sequence type 131 lineage C1-M27 clone in clinical isolates. Germany Emerg Infect Dis. 2017;23(10):1754\u20136.","journal-title":"Germany Emerg Infect Dis"},{"key":"1150_CR79","doi-asserted-by":"crossref","unstructured":"Mills EG, Martin MJ, et al. A one-year genomic investigation of Escherichia coli epidemiology and nosocomial spread at a large U.S. healthcare network. Natl Cent Biotechnol Inf. 2022; Available from: https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/?term=PRJNA809394.","DOI":"10.1186\/s13073-022-01150-7"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01150-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01150-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01150-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T12:51:53Z","timestamp":1679230313000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01150-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01150-7","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The isolates and clinical information were collected as part of the public health surveillance activities of the MRSN, as determined by the WRAIR branch director and Human Subjects Protection Branch (HSPB) which granted ethical approval. Informed patient consent was waived as samples were taken under a hospital surveillance framework for routine sampling. The research conformed to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}